EPIDEMIOLOGY AND RISK FACTORS FOR HEPATITIS “C” VIRUS INFECTION IN SUSPECTED POPULATION VISITING DHQ HOSPITAL DERA ISMAIL KHAN, PAKISTAN
Main Article Content
Keywords
HCV, ICT, Blood Transfusion, IDUs, DHQ Hospital D.I. Khan
Abstract
Hepatitis C virus (HCV) infections have varied prevalence rates across locations, which makes them a major public health concern worldwide. A cross-sectional research design collected data from a statistically significant subset of hospital visitors. A mix of structured interviews and serological testing determined the seroprevalence of hepatitis C virus infection. Data on potential risk factors, including demographics, medical history, and behavioral patterns, were also collected. Concerningly, 23.4% of the people surveyed tested positive for hepatitis C viral antibodies, suggesting a worrying expansion of HCV infection among the community under study. In addition, our research has identified several significant risk factors associated with an increased likelihood of contracting Hepatitis C virus infection. These include injectable drug use, a history of smoking, receiving blood transfusions, and having dental surgery, among others. The results add much to our knowledge of the hepatitis C virus epidemiology in Dera Ismail Khan. This study stresses the need for targeted screening, intervention, and preventive programs. Furthermore, there is a need to address modifiable risk factors to reduce the spread of HCV in this specific region.
References
2. Romanivna, M. S., Olehivna, G. O., & Yaroslavovich, S. D. (2023). INCIDENCE AND PREVALENCE OF HEPATITIS C IN UKRAINE AND THE WORLD. Paper presented at the Colloquium-journal.
3. Khan, M. K., Saad, M., & Ullah, R. (2021). A Concise Review on Hepatitis C Virus Infection-Associated Type 2 Diabetes Mellitus and Its Impact on Anti-HCV Therapy.
4. Chatterjee, S., Majumder, B., & Basu, D. (2021). A review to explore the association between diabetes mellitus and hepatitis. metabolism, 35(36), 37.
5. Sohail, A. (2023). Awareness and Prevalence of Hepatitis B and C in Rural Areas of Lahore, Pakistan.
6. Yechezkel, I., Law, M., & Tzarum, N. (2021). From structural studies to HCV vaccine design. Viruses, 13(5), 833.
7. Saleem, U., Aslam, N., Siddique, R., Iqbal, S., & Manan, M. (2022). Hepatitis C virus: Its prevalence, risk factors and genotype distribution in Pakistan. European Journal of Inflammation, 20, 1721727X221144391.
8. Abdel-Gawad, M., Nour, M., El-Raey, F., Nagdy, H., Almansoury, Y., & El-Kassas, M. (2023). Gender differences in prevalence of hepatitis C virus infection in Egypt: a systematic review and meta-analysis. Scientific Reports, 13(1), 2499.
9. Organization, W. H. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016–2021: actions for impact: World Health Organization.
10. Haqqi, A., Munir, R., Khalid, M., Khurram, M., Zaid, M., Ali, M., . . . Afzal, M. S. (2019). Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral immunology, 32(9), 402-413.
11. Khan, M. K., Saad, M., & Ullah, R. (2021). A Concise Review on Hepatitis C Virus Infection-Associated Type 2 Diabetes Mellitus and Its Impact on Anti-HCV Therapy.
12. McCarthy, R. V., McCarthy, M. M., Ceccucci, W., McCarthy, R. V., McCarthy, M. M., & Ceccucci, W. (2022). What do descriptive statistics tell us. Applying predictive analytics: Finding value in data, 55-85.
13. Niu, Z., Zhang, P., & Tong, Y. (2016). Age and gender distribution of Hepatitis C virus prevalence and genotypes of individuals of physical examination in WuHan, Central China. Springerplus, 5, 1-9.
14. Jin, F., Dore, G. J., Matthews, G., Luhmann, N., Macdonald, V., Bajis, S., . . . Grulich, A. E. (2021). Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. The lancet Gastroenterology & hepatology, 6(1), 39-56.
15. Roy, É., Arruda, N., Leclerc, P., Haley, N., Bruneau, J., & Boivin, J.-F. (2012). Injection of drug residue as a potential risk factor for HCV acquisition among Montreal young injection drug users. Drug and alcohol dependence, 126(1-2), 246-250.
16. Basit, A., Rahim, K., Ahmad, I., Shafiq, M., Mushtaq, S., Shaheen, H., & Khan, I. (2014). Prevalence of hepatitis B and C infection in Pakistan. J Inf Mol Biol, 2(3), 35-38.
17. Antonelli, A., Ferri, C., Galeazzi, M., Giannitti, C., Manno, D., Mieli-Vergani, G., . . . Palazzi, C. (2008). HCV infection: pathogenesis, clinical manifestations and therapy. Clinical and Experimental rheumatology, 26(2), S39.
18. Munir, A. (2023). Prevalence of Hepatitis B Virus and Hepatitis C Virus in Sub Division Ladha, South Waziristan: Prevalence of Hepatitis B Virus and Hepatitis C Virus. Journal of Animal and Plant Research, 1(1), 1-4.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Abdus Sami
Qurtuba University of Science and Information Technology Dera Ismail Khan
Areesha Arshad
Islamabad Medical and Dental College
Aqsa Mustafa
Baqai Medical University
Nadir Akhtar
HEELA Institute for Research and Development, Islamabad
Usama Khan
Nowshera Medical College, Nowshera
Syed Owais Akhtar
Jinnah Sindh Medical University
Aisha Akhtar
Liaquat University of Medical and Health Science Jamshoro
Kaleem Ullah
Jiangsu University of Science and Technology China